NCT01708798View on ClinicalTrials.gov

Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast Cancer

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Breast Cancer
Interventions
DRUG

Eplerenone

DRUG

Placebo

Trial Locations (1)

V5Z 4E6

British Columbia Cancer Agency, Vancouver Centre, Vancouver

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Canadian Cancer Society (CCS)

OTHER

collaborator

Pfizer

INDUSTRY

lead

University of British Columbia

OTHER